Mehmet Sayiner, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States
Hepatol Commun .
3(3):356-364
Date: 01 2019
https://pubmed.ncbi.nlm.nih.gov/30859148/

Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide
Liver Transpl .
25(1):10-11
Date: 01 2019
https://pubmed.ncbi.nlm.nih.gov/30472779/

Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use
Hepatology .
69(1):237-244
Date: 01 2019
https://pubmed.ncbi.nlm.nih.gov/30015376/

Disease Burden of Hepatocellular Carcinoma: A Global Perspective
Dig Dis Sci .
64(4):910-917
Date: 04 2019
https://pubmed.ncbi.nlm.nih.gov/30835028/

Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
Hepatol Commun .
3(8):1050-1060
Date: 06 2019
https://pubmed.ncbi.nlm.nih.gov/31388626/

Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients
Dig Dis Sci .
65(2):416-422
Date: 02 2020
https://pubmed.ncbi.nlm.nih.gov/31451982/

Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population
Hepatol Int
14(4):556-566
Date: 07 2020
https://pubmed.ncbi.nlm.nih.gov/32300995/

Clinical outcomes and financial impacts of malnutrition in sepsis.
Nutr Health
26(3):175-178
Date: 09 2020
https://pubmed.ncbi.nlm.nih.gov/32571151/